Skip to content

Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes

Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes: Phase 3b Multi-center Trial for Model Development

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06212518
Enrollment
1000
Registered
2024-01-19
Start date
2023-10-02
Completion date
2024-08-31
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration

Keywords

hydration, dehydration, euhydration, hypohydration, exercise, Transdermal Optical Imaging, TOI

Brief summary

The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hydration status, including: 1) at various timepoints throughout a 24-hour period in healthy adults from the general population (GENPOP), and 2) before and after a team coach-led training session in athletes competing in a sport (ATHLETE). TOI data will be collected alongside standard reference measures of hydration status. In this study each subject will serve as their own control.

Interventions

OTHERGENPOP ad libitum fluid intake

Unrestricted fluid intake.

OTHERGENPOP fluid restriction

In the 24 hours between the first and last face scan, reduce fluid intake by approximately 75% (equating to approximately 700 ml (women) and 800 ml (men)).

OTHERATHLETE ad libitum fluid intake

No restriction on fluid intake

OTHERATHLETE restricted fluid intake

Not permitted to drink during training session.

Sponsors

PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Both Study Arms (GENPOP and ATHLETE) * Subject is male or female * If female, subject is not pregnant * Subject is willing to avoid alcohol consumption 24 hours prior to visit(s) * Subject is willing to avoid wearing makeup to the study session or willing to remove it with facial wipes before the face scans * Subject is willing to shave facial hair if predetermined during the informed consent session it will interfere with TOI measurement * Able to speak, write, and read English * Provision of written consent to participate GENPOP Study * Study subject is 18-65 years of age, inclusive * Subject does not smoke (or has quit for at least 6 months) * Subject is not taking medication that may interfere with the study * Subject has no health conditions that would prevent completion of the trial as indicated on the general health questionnaire (GHQ) * Subject is willing to fast overnight (\ 8-12 hours) * Subject is willing to refrain from vigorous exercise for 48 hours * Subject is willing to eat the exact same food the day prior to each visit to the testing site ATHLETE Study * Study subject is 14-45 years of age, inclusive * Subject is participating in team sport training/competition * Subject is participating in a coach-led practice

Exclusion criteria

Both Study Arms (GENPOP and ATHLETE) * Subject has participated or currently enrolled in a clinical trial within the past 30 days * Subject has participated in any PepsiCo trial within past 6 months * Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk * Subject is allergic to alcohol or facial cleansing wipes * Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent. GENPOP Study • Subject has a health condition or is taking medication that can be worsened by fluid restriction (participants who opt-in to fluid restriction study arm only)

Design outcomes

Primary

MeasureTime frameDescription
Transdermal Optical Imaging (TOI) signalsFour time points for GENPOP over 24 hours (Day 1 ~8 a.m., ~11:30 a.m., ~3:30 p.m., Day 2 ~8.a.m.; for ATHLETES, on arrival before a single ~45 minute exercise training session and immediately following a 30 minute cool down period post-exerciseBlood flow patterns of the face obtained from the video camera on a smart phone
Standard measurement of hydration status: Body mass changeFour time points for GENPOP over 24 hours (Day 1 ~8 a.m., ~11:30 a.m., ~3:30 p.m., Day 2 ~8.a.m.; for ATHLETES, upon arrival before a single ~45 minute exercise training session and again immediately after exerciseBody mass scale (Tanita, WB-800 Plus) to the nearest 0.01 kilogram (kg)
Standard measurements of hydration status: Urine specific gravityFour time points for GENPOP over 24 hours (Day 1 ~8 a.m., ~11:30 a.m., ~3:30 p.m., Day 2 ~8.a.m.; for ATHLETES, upon arrival before a single ~45 minute exercise training session and again immediately after exerciseDigital pen refractometer (Atago, PEN-Urine SG)
Standard measurements of hydration status: Urine colorFour time points for GENPOP over 24 hours (Day 1 ~8 a.m., ~11:30 a.m., ~3:30 p.m., Day 2 ~8.a.m.; for ATHLETES, upon arrival before a single ~45 minute exercise training session and again immediately after exerciseColor range scale rated from dilute to concentrated. 1=clear through yellows and oranges with most orange =7
Standard measurements of hydration status: ThirstFour time points for GENPOP over 24 hours (Day 1 ~8 a.m., ~11:30 a.m., ~3:30 p.m., Day 2 ~8.a.m.; for ATHLETES, on arrival before a single ~45 minute exercise training session and immediately following a 30 minute cool down period post-exerciseCategorical scale from 1=Not thirsty at all, to 7=very, very thirsty

Secondary

MeasureTime frameDescription
Mood scaleFour time points for GENPOP over 24 hours (Day 1 ~8 a.m., ~11:30 a.m., ~3:30 p.m., Day 2 ~8.a.m.; for ATHLETES, on arrival before a single ~45 minute exercise training session and immediately following a 30 minute cool down period post-exerciseRated from 1=Calm to 9=Irritated
Subject demographics - AgeAt screeningin years
Dietary and fluid intakeFor GENPOP from 24 hours prior to Day 1 visit (~8 a.m.) through end of testing period (Day 2 ~8 a.m.). For ATHLETES from 24 hours to prior to start of single ~45 minute exercise session (if fluid restricted) or to end of exercise (if ad lib fluid intake)Food and fluid intake recorded on a paper log
Subject demographics - SexAt screeningmale or female
Subject demographics - EthnicityAt screeningHispanic or Latino, or not Hispanic or Latino
Subject demographics - RaceAt screeningAmerican Indian, Alaska native, Asian, Black or African American, Native Hawaiian or Pacific Islander, White
Fitzpatrick classification of skin colorAt screeningSkin type from 1=White skin, always burns, never tans to 6 = Black skin, heavily pigmented, never burns, tans very easily

Countries

United States

Contacts

Primary ContactMatthew Hinkley, PhD
Matt.Hinkley@pepsico.com914-742-4975

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026